Nanotechnology in Stroke: New Trails with Smaller Scales

Stroke is a leading cause of death, long-term disability, and socioeconomic costs, highlighting the urgent need for effective treatment. During acute phase, intravenous administration of recombinant tissue plasminogen activator (tPA), a thrombolytic agent, and endovascular thrombectomy (EVT), a mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Toljan, Karlo, Ashok, Anushruti, Labhasetwar, Vinod, Hussain, M. Shazam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045028/
https://www.ncbi.nlm.nih.gov/pubmed/36979759
http://dx.doi.org/10.3390/biomedicines11030780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045028/
https://www.ncbi.nlm.nih.gov/pubmed/36979759
http://dx.doi.org/10.3390/biomedicines11030780

Ejemplares similares